AME posts 62% rise in H1 2022 profit to SAR 15.4 mln

AME posts 62% rise in H1 2022 profit to SAR 15.4 mln

21/08/2022 Argaam Exclusive

View other reports

AME Company for Medical Supplies posted a 62% rise in H1 2022 net profit after Zakat and tax to SAR 15.4 million, from SAR 9.5 million a year earlier.



Financials (M)

Item 6m 2021 6m 2022 Change‬
Revenues 69.78 108.35 55.3 %
Gross Income 32.00 48.86 52.7 %
Operating Income 13.27 17.25 30.0 %
Net Income 7.50 15.38 105.1 %
Average Shares 7.00 7.00 -
EPS (Riyals) 1.07 2.20 105.1 %

The profit growth was driven by an increase of SAR 54.28 million year-on-year (YoY) in the sales of medical supplies and devices. This surge resulted from the company’s acquisition of a larger market share, thanks to its participation in local and international conferences, exertion of more efforts to advertise and market its products, as well as the appointment of new employees in the sales and marketing departments to serve customers faster.



Current Quarter Comparison (M)

Compared With The
Item Q2 2021 Q2 2022 Change‬
Revenues 37.62 54.06 43.7 %
Gross Income 16.83 26.64 58.3 %
Operating Income 7.00 10.28 46.9 %
Net Income 1.92 9.51 395.1 %
Average Shares 7.00 7.00 -
EPS (Riyals) 0.27 1.36 395.1 %

Shareholders’ equity, after minority interest, rose to SAR 96.942 million as of June 30, 2022, from SAR 93.414 million in the prior-year period.

View More Financial Results

 


Financial results (Million)

Period Revenues Change Gross Income Change Net Income Change EPS(Riyal)
Q1 2013 - - - - - - -
Q2 2013 - - - - - - -
Q3 2013 - - - - - - -
Q4 2013 - - - - - - -
Q1 2014 - - - - - - -
Q2 2014 - - - - - - -
Q3 2014 - - - - - - -
Q4 2014 - - - - - - -
Q1 2015 - - - - - - -
Q2 2015 - - - - - - -
Q3 2015 - - - - - - -
Q4 2015 - - - - - - -
Q1 2016 - - - - - - -
Q2 2016 - - - - - - -
Q3 2016 - - - - - - -
Q4 2016 - - - - - - -
Q1 2017 - - - - - - -
Q2 2017 - - - - - - -
Q3 2017 - - - - - - -
Q4 2017 - - - - - - -
Q1 2018 - - - - - - -
Q2 2018 - - - - - - -
Q3 2018 - - - - - - -
Q4 2018 - - - - - - -
Q1 2019 - - - - - - -
Q2 2019 - - - - - - -
Q3 2019 - - - - - - -
Q4 2019 - - - - - - -
Q1 2020 31.44 - 15.42 - 3.36 - 0.48
Q2 2020 - - - - - - -
Q3 2020 - - - - - - -
Q4 2020 - - - - - - -
Q1 2021 32.16 2.3 % 15.17 (1.6 %) 5.58 65.9 % 0.80
Q2 2021 37.62 - 16.83 - 1.92 - 0.27
Q3 2021 - - - - - - -
Q4 2021 - - - - - - -
Q1 2022 54.29 68.8 % 22.22 46.5 % 5.87 5.3 % 0.84
Q2 2022 54.06 43.7 % 26.64 58.3 % 9.51 395.1 % 1.36

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 49.05 % - 10.69 %
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 48.10 % - 14.06 %
Q2 2021 46.85 % - 15.00 %
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 44.78 % - 13.54 %
Q2 2022 45.39 % - 15.27 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2013 - - - -
Q2 2013 - - - -
Q3 2013 - - - -
Q4 2013 - - - -
Q1 2014 - - - -
Q2 2014 - - - -
Q3 2014 - - - -
Q4 2014 - - - -
Q1 2015 - - - -
Q2 2015 - - - -
Q3 2015 - - - -
Q4 2015 - - - -
Q1 2016 - - - -
Q2 2016 - - - -
Q3 2016 - - - -
Q4 2016 - - - -
Q1 2017 - - - -
Q2 2017 - - - -
Q3 2017 - - - -
Q4 2017 - - - -
Q1 2018 - - - -
Q2 2018 - - - -
Q3 2018 - - - -
Q4 2018 - - - -
Q1 2019 - - - -
Q2 2019 - - - -
Q3 2019 - - - -
Q4 2019 - - - -
Q1 2020 7.00 0.48 0.48 -
Q2 2020 - - - -
Q3 2020 - - - -
Q4 2020 - - - -
Q1 2021 7.00 1.28 1.28 -
Q2 2021 7.00 1.55 2.17 11.72
Q3 2021 - - - -
Q4 2021 - - - -
Q1 2022 7.00 2.39 3.01 -
Q2 2022 7.00 3.27 3.89 13.79

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 23.43 18.62 -
Q2 2022 13.31 11.20 3.15

Business Segments (Million)

Compared With The
Period Medical supplies medical tools Maintenance & Management sector Others


Financial Ratios
Current
Market Cap (M Riyal) 415.10
Enterprise Value (EV) (M) 371.70
Shares Outstanding ((M)) 7.00
Book Value (BV) ( Riyal) 18.17
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 12.39
Price/book 3.26
more

Share Price

AME Company for Medical Supplies
59.30
(0.20) (0.34 %)

AME Company for Medical Supplies (AME)

More

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.